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Thymus-dependent,  helper  cells  ("T"  lymphocytes)  1 and  thymus-independent, 
antibody-forming precursor cells  ("B" lymphocytes)  cooperate  in  the  initiation  of 
the primary antibody response of rodents  to a  variety of antigens  (1-3).  Both cell 
lines  also cooperate in the initiation  of  the secondary antibody response, and both 
carry  immunological  memory  (4,  5).  Recent  cell  transfer  studies  indicate  that  B 
memory cells determine the changes in the proportion of immunoglobulin classes and 
affinity of antibodies produced in the secondary response  (6-8). These changes sug- 
gest that B memory cells are not derived by a simple expansion of unprimed B lympho- 
cytes, but rather by heterogeneous expansion of subpopulations of unprimed B lym- 
phocytes or by a qualitative change in immunological function. 
On  the  other  hand,  the  carriage  of  immunological  memory  by  T  lymphocytes 
could be  explained  by a  homogeneous expansion  of unprimed T  cells.  Miller  et al. 
(5) and Mitchell et al. (4) have shown that both primed and unprimed T lymphocytes 
are able to cooperate with primed B lymphocytes in the adoptive secondary antibody 
response of mice to fowl gamma globulin and sheep red blood cells  (SRBC), respec- 
tively. Approximately, ten times as many unprimed as primed T  lymphocytes were 
required  to restore responses of equal magnitude (4, 5).  However, the adoptive sec- 
ondary response to either antigen could not be restored by a  combination of primed 
T  lymphocytes and large numbers of unprimed B lymphocytes (4,  5). This suggests 
that a  fundamental change in the immunological function of B  but not T  lympho- 
cytes occurs after priming. 
The present  work was designed  to determine  whether  priming changes  the 
life-span and migratory behavior of B lymphocytes as well. Our previous studies 
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provide indirect evidence for these changes, since unprimed and primed lympho- 
cytes which  restore  the adoptive antibody  response  to diphtheria  toxoid  (DT) 
and horse spleen ferritin (HSF) in rats differ in their distribution in the lymph- 
oid tissues (9),  and in their sensitivity to the mitotic inhibitor, vinblastine  (10). 
The  present  results  provide  direct  evidence  for  physiological  changes  in  un- 
primed  and  primed  B  cells.  In particular,  the findings  indicate  that  unprimed 
B  lymphoctyes are short-lived (newly formed) cells which are unable to recircu- 
late from the blood to the lymph,  and  that primed B  lymphocytes  (B memory 
cells) in the thoracic duct lymph are long-lived, recirculating cells. 
Materials and Methods 
Animals.--Inbred Lewis rats were used in all experiments. Animals were purchased from 
Microbiological Associates, Inc., Bethesda, Md. 
Preparation of Cell Suspenslons.--The thoracic duct of adult male rats was cannulated by 
a modification of the procedure of Bollman et al.  (11). Rats were maintained unanesthetized 
in restraining cages and received a continuous intravenous infusion of Ringer's solution con- 
taining streptomycin  (0.1 mg/ml) and  heparin  (1 unit/ml)  at  2 ml/hr. Thoracic duct cells 
were collected at 4°C for 24 hr  (unless  otherwise indicated in the text)  in 5 ml of Ringer's 
solution with 100 units of heparin and 1 mg of streptomycin. Cells were harvested by centrifu- 
gation at 150 g for 10 mln and resuspended in tissue culture medium 199  (Grand Island Bio- 
logical Co., Grand Island, N.Y.)  before injection. Spleen  cell suspensions  were made in me- 
dium 199 according to the technique of Billingham (12). 
X-Irradiation.--Rats  were placed in Lucite containers  and  received 500  R  whole body 
X-irradlation (except as noted in the text) from a single 250 kv (15 amp) source.  The source 
axis distance was 52 cm, and the dose  rate was  105 R/rain  (0.25  mm of Cu  +  0.55 mm of 
A1 filtration). 
Neonatal Thymectomy.--Neonatal  thymectomy was performed within 24 hr of birth by a 
modification of the technique of Miller  (13).  The mediastinum of thymectomized rats was 
examined for gross and microscopic evidence of thymus remnants at the end of each experi- 
mental protocol. Animals with remnants were discarded from the study. 
Immunization  Procedures.--Rats  were immunized to aluna-adsorbed  DT  (Parka, Davis & 
Co., Detroit, Mich.) by a single subcutaneous  (7.5 Lf, 0.25 ml) and intraperitoneal injection 
(7.5 Lf, 0.25  hal) of  15 Lf toxoid. Bovine serum albumin  (BSA)  (Nutritional Biochemicals 
Corp.,  Cleveland, Ohio)  and  fluid  DT  (Commonwealth  of  Massachusetts  Department  of 
Health) were dinitrophenylated  (DNP)  by the procedure of Eisen et al.  (14). The composi- 
tion  of  the  conjugates  was  DNP3~-BSA  and  DNP13-DT.  Rats  immunized  to  DNP-BSA 
received 0.1 ml of an emulsion  of equal volumes DNP-BSA in phosphate-buffered saline and 
complete Freund's adjuvant  (Difco Laboratories, Inc., Detroit, Mich.) in each hind footpad 
to give a total dose of 0.4 mg of protein per animal. Rats challenged with DNP-DT received 
a  single intraperitoneal injection of 0.5  mg of protein in  1 ml of phosphate-buffered  saline. 
Immunization to HSF (Pentex Biochemical, Kankakee, Ill.) was accomplished by the injec- 
tion of 0.1 ml of emulsion of equal volumes HSF in saline and  complete Freund's adjuvant 
into each hind footpad. Each rat received a total dose of 2  mg of HSF. 
Antibody  Titrations.--Antibodies  to DT and HSF were measured  in microtiter agglutina- 
tion plates (Cooke Engineering Co., Alexandria, Va.)  by a modification of the tanned red cell 
hemagglutination technique of Stavitsky (15). Fresh sheep cells were used  in all assays,  and 
tanning and  sensitization were carried out a few hours before the titration procedure. Mer- 
captoethanol(ME)-resistant  antibody was measured by incubating equal volumes of a  1:10 
dilution of whole antiserum and 2-ME (0.1 .~.~ in saline)  for 30 rain at room temperature before 
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Antibodies to DNP were measured by a previously described (16) modification of the Farr 
assay (17). Serial fivefold dilutions of antiserum were made in 20% normal rat serum in saline. 
Diluted antisera were incubated with 10  -s ~t DNP3H-ethylaminocaproic acid  (kindly sup- 
plied by Dr. R. A. Asofsky, National Institute for Allergy and Infectious Diseases, Bethesda, 
Md.) for at least 1 hr at room temperature. Globulins were precipitated with 50% saturated 
ammonium sulfate for an additional  1 hr. Aliquots of the supernatant were counted in a 
scintillation counter, and antibody titers were recorded as the logl0 of that dilution of anti- 
serum which bound 33% of the labeled ligand. 
In Vitro Labeling of Thoracic Duct Cells with Uridine-3H.--Thoracic duct cells (10  T  cells/ml) 
were incubated in vitro in a culture medium containing medium 199 with 5% fetal calf serum 
and 1/zCi/ml uridine3H  (New England Nuclear Corp., Boston, Mass.; specific  activity 20 
mCi/mmole). The incubation mixture was agitated slowly in a 37°C water  bath for 45 rain. 
The cells were washed twice in medium 199 before preparation of smears or intravenous in- 
jection. 
Radioautography.--Radioautographs of uridine3H-labeled cells were prepared with Kodak 
NTB emulsion (Eastman Kodak Co., Rochester, N. Y.). Slides were exposed for 17-21  days 
before developing and application of Giemsa stain. 
In Vitro Incubation of Thoracic Duct Cdls with Thymidine3H.--Thoracic duct cells (1-2 X 
107 cells/ml) were incubated in a tissue culture medium containing Ham's F12 medium with- 
out thymidine (Hyland Laboratories, Costa Mesa, Calif.),  10%  (v/v) fetal calf serum, and 
thymidine-*H  (New England  Nuclear Corp.; specific activity  15 mCi/mmole) at  a concen- 
tration of 10/zCi/ml. The incubation mixture was placed in a  10 cm diameter plastic Petri 
dish  (Falcon Plastics, Inc., Division of B-D Laboratories, Inc., Los Angeles, Calif.) which 
was maintained at 37°C for 24 hr in an atmosphere of 95% 02 and 5% CO2. Approximately 
85-100% of cells were recovered and viability was greater than 90% as judged  by trypan 
blue dye exclusion. Incubated ceils were washed three times in medium  199 with 5% fetal 
calf serum before intravenous injection. 
Intravenous Injection of Cells.--Cell suspensions were always made up in 0.5-1 ml of me- 
dium 199 and injected into the lateral tail vein of anesthetized rats. 
Bleeding Procedures.--Anesthetized rats were bled from the tail vein on the days indicated 
in the figures. Approximately 0.2-0.5 ml of blood was allowed to clot at room temperature 
for 1 hr and then refrigerated for 12 hr. Serum was removed and stored at -20°C after cen- 
trifugation at 200 g for 10 min. 
RESULTS 
Inability  of  Unprimed  Thoracic  Duct Cells to  Restore  the Adoptive Antibody 
response  to  DT.--Adult  male  Lewis  rats  weighing  150-200  g  received  500  R 
whole body X-irradiation and either spleen cells or thoracic duct cells from nor- 
mal  (unimmunized)  donors  2  hr later.  Each  recipient was  challenged with  15 
Lf  alum-adsorbed  DT  24  hr  after  irradiation.  Although  1  X  l0  s  spleen  cells 
restored a  moderate anti-to×old response,  1  X  109 thoracic duct cells did not re- 
store  a  detectable  response by day 20 (Fig. 1). Drainage  of  the thoracic  duct 
of normal rats for 5 days before challenge with DT  did not significantly decrease 
the anti-toxoid response  as compared  with intact controls  (Fig.  1). 
Restoration of the Adoptive Antibody Response to DT with DT-Primed Thoracic 
Duct Cells.--Adult  male  rats were  primed  with  15 Lf  alum-adsorbed  DT  and 
thoracic  duct  cells were  collected  4-8  wk  later.  Graded  numbers  of  cells were 
transferred  to  sublethally  irradiated  (500  R)  rats  and  each  animal  was  chal- 
lenged with DT  as described  in  the previous  section.  As few  as  1  X  107  cells 854  PItYSIOLOGICAL  CHANGES  IN  B  LYMPHOCYTES 
restored a vigorous response by day 7 (Fig. 2). The log10 cell dose vs.  antibody 
titer plot was linear in this dose range (Fig. 2). 
In order to determine whether residual radioresistant cells make a  contribu- 
tion  to  the  adoptive antibody response  after sublethal irradiation,  the  above 
experiments were repeated with groups of three animals each receiving 1000 R. 
Antibody titers in these groups at day 7 were almost identical with those shown 
in Fig. 2 for the three cell doses. 
Restoration of the Adopti~,e Antibody  Response to DT with Primed  Thoracic 
Duct Cells Passaged through an Intermediate Host.--The migratory characteris- 
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FIG. 1.  Antibody response of rats to a single subcutaneous  and intraperitoneal injection of 
15 Lf alum-adsorbed DT.  O--e, Mean response of 12 normal rats. Brackets show  range of 
titers. D---i, Mean response of five rats after drainage of the thoracic duct for  5 days. DT 
was injected immediately after the cannula  was removed.  A--A, Mean response  of  eight 
rats given 500 R, whole body X-irradiation  24 hr before immunization.  [3--[3, Mean response 
of 10 rats given an intravenous injection of 1 X  10  s spleen cells from unimmunized  syngeneic 
donors  2 hr after irradiation. DT was injected 22 hr later. O--O, Mean response  of four 
irradiated rats given an intravenous injection of 1 X 109 thoracic duct cells from unimmunized 
syngeneic donors. DT was injected 22 hr later. 
tics of DT-primed thoracic duct cells remained to be elucidated, since both re- 
circulating and nonrecirculating cells are found in the thoracic duct lymph of 
the rat (18, 19). Accordingly, DT-primed cells were injected intravenously into 
normal rats and  the thoracic duct of these intermediate hosts was cannulated 
24 hr later. Thoracic duct cells were collected for 24 hr and then transferred to 
irradiated hosts which were subsequently challenged with DT. 
In order to determine the yield of donor DT-primed cells in the lymph of the 
intermediate host,  preliminary experiments were performed in which 5  X  10  s 
thoracic duct  cells from normal donors were labeled in vitro for 45  min  with 
uridine-aH and  injected intravenously into a  normal adult recipient. Thoracic 
duct cells were collected from 24 to 48 hr later and the per cent labeled cells in SAMUEL  STROBER  855 
the 24 hr lymph collection was examined by radioautography. Table I  shows 
the average per cent labeled cells (200 cells counted) in donor (87 %) and host 
(11%)  lymph in two experiments. A  considerable reduction in the proportion 
of labeled large and medium cells (>8  ~  diameter) was noted in host as com- 
pared with donor lymph. These  results were used to calculate the number  of 
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FIG. 2.  Adoptive antibody response of rats at day 7 to a single subcutaneous  and intra- 
peritoneal injection of 15 Lf alum-adsorbed DT.  O, Mean response of rats given an intra- 
venous injection of thoracic duct cells from DT-primed donors 2 hr after 500 R whole body 
X-irradiation. DT was injected 22 hr later, e, Mean response of irradiated rats given tho- 
racic duct cells passaged through a normal intermediate host.  Brackets show the standard 
error of the mean. There were four to seven rats in each group. 
TABLE I 
Recovery of Uridine-~H-Labded Cells in Rat Thoracic Duct Lymph 
Per cent labeled  cells  Per cent large lymphocytes 
amongst labeled  cells 
%  % 
Donor thoracic duct cells  87.5  7 
Host thoracic duct cells  it  <0.5 
passaged cells from DT-pfimed donors injected into the irradiated hosts, since 
intermediate hosts always received 5  X  108 donor cells. 
Fig. 2 shows that the anti-DT response restored by primed, passaged cells at 
day 7 was slightly higher than that of primed, unpassaged cells at two different 
cell doses. However,  differences between  the  two  groups were  not  significant 
(P >  0.05)  as judged by the  Student's t test. 
Restoration  of  the  Adoptive  Antibody  Response  to  DNP-DT  with  Passaged 
Primed  Cells.--Although  the  results  of  the  previous  section  show  that  DT- 
primed thoracic duct cells are able to recirculate from the blood to the lymph, 
the contribution of helper cell (T cell) and antibody-forming precursor cell (B 856  PHYSIOLOGICAL  CHANGES  IN  B  LYMPHOCYTES 
cell) activity was not assessed. A decrease in the precursor cell activity of pas- 
saged cells could have been  masked by an increase in  helper cell  activity.  In 
order to assess both helper and precursor cell activity, several experiments were 
performed in which a combination of carrier and hapten-primed cells were used 
to  restore  the  adoplive  antibody  response  to DNP-DT.  We  have previously 
shown that both cell types cooperate in the initiation of the anti-DNP response 
to this hapten-protein conjugate (20). 
Fig. 3 shows the experimental scheme in which graded numbers of DT-primed 
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Fro. 3.  Experimental scheme. Inbred  Lewis rats are immunized with DNP-BSA  or DT. 
DT-primed  thoracic  duct  cells are injected  intravenously into  normal syngeneic hosts and 
recovered in the thoracic duct lymph. The passaged DT-primed cells and nonpassaged DNP- 
primed cells are injected into a  syngeneic recipient which received 500 R  2 hr before. Recipi- 
ents are challenged with DNP-DT  22 hr later. 
thoracic duct cells were passaged through  a normal intermediate host  and in- 
jected  together  with  25  X  10  ~ DNP-primed  cells  into  an  X-irradiated  host. 
DNP-DT was injected intraperitoneally 24 hr  after irradiation.  The  adoptive 
anti-DT response was taken as a measure of B or precursor cell activity and the 
anti-DNP response was taken as a measure of T  or helper cell activity (21, 22). 
Both  10  and  25  X  10"  unpassaged,  DT-primed cells produced  anti-DT  and 
anti-DNP  responses which were easily detectable by day 7  (Fig. 4). A  greater 
difference was noted  between  the  anti-DT  response restored  by the  two  cell 
doses as compared with the anti-DNP response. The anti-DT response restored 
by 16 X  10  ~ passaged, DT-primed cells fell between the responses restored by 
10  and  25  X  106  unpassaged  cells.  The  anti-hapten  response restored by the SAMUEL  STROBER  857 
passaged cells did not differ  significantly (P >  0,1) at days 10 and 14 from the 
responses restored by 10 or 25  X  106 unpassaged cells. 
Restoration of the Adoptive Antibody  Response to DNP-DT with Primed  Cells 
from Donors Treated with  Thymidine-bH.--In  further  experiments  the  rate  of 
formation (turnover rate) of helper and precursor cells involved in the adoptive 
secondary response to DNP-DT was studied. DT-primed donors weighing 125- 
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FIG. 4.  Adoptive antibody response  of rats to a single intraperitoneal injection of 0.5 mg 
of DNP-DT. All rats were given 25 X  106 nonpassaged DNP-primed thoracic duct cells and 
graded numbers of DT-primed thoracic duct cells intravenously 2 hr after 500 R whole body 
X-irradiation. DNP-DT was given 22  hr later.  (a)  Mean anti-DT response  of groups of five 
to nine rats with brackets showing the standard error of the mean.  (b) Mean anti-DNP re- 
sponse expressed as log10 titer which bound 33%  of labeled antigen.  0--0,  Mean response 
of rats given  25  X  106 nonpassaged DT-primed ceils;  O--©,  mean response  of rats given 
10  ;<  106 nonpassaged DT-primed cells;  []--[], mean response  of rats given 16  ;<  106 pas- 
saged DT-primed cells.  ~--~,  Mean response  of rats given 25 M 106 DT-primed cells treated 
in vivo with thymidinebH. 
150 g  received  intraperitoneal injections of  thymidine-bH  (New  England Nu- 
clear Corp. ; specific activity 15 mCi/mmole)  in aqueous solution every 8 hr for 
a period of 48 hr before cannulation of the thoracic duct. Each dose of thymi- 
dine-bH contained 3.5 mCi in 3.5 ml of sterile water (24.5 mCi total dose). 
Thoracic duct cells from thymidine-SH-treated donors were collected for  24 
hr and then injected together with DNP-primed  cells into irradiated hosts as 
described before. The thoracic duct cell output of the treated donors was about 
equal to that of untreated rats. In order to minimize reutilization of the radio- 
active label, each host received a single intraperitoneal injection of cold thymi- 
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dine  (1  ml,  10  --4 M thymidine in water)  within  a few hours  after cell transfer. 
Cold thymidine was also added to the drinking water (10  .4 ~) for the remainder 
of the experiment. DNP-DT was administered to each host 24 hr after irradia- 
tion. 
Fig. 4 shows that the anti-DT and anti-DNP responses restored by a combi- 
nation  of 25  X  l06  treated,  DT-primed cells and  25  X  106 untreated,  DNP- 
primed cells was similar to that restored by 10 X  106 DT- and 25 X  106 DNP- 
primed cells from untreated donors. 
Inability of Passaged Thoracic Duct Cells from Normal Donors to Restore the 
Adoptive  Primary Antibody  Response to HSF.--Although  thoracic  duct  cells 
from normal rats do not restore the adoptive primary response to alum-adsorbed 
DT, these cells do restore the primary response to HSF (10). In order to deter- 
mine the migratory characteristics of the active cells,  passaged and unpassaged 
thoracic duct cells were tested for their ability to restore the adoptive anti-HSF 
response of irradiated hosts. Accordingly, 5 X  l0  s thoracic duct cells from nor- 
mal donors were injected intravenously into syngeneic intermediate hosts which 
had received 500 R  24 hr before. The thoracic duct of the intermediate hosts 
was cannulated  24 hr after the injection,  and cells were collected for a period 
of 48 hr.  The passaged cells were subsequently injected intravenously into ir- 
radiated hosts challenged with HSF. Equal numbers of passaged cells were in- 
jected 2  and 24 hr after irradiation,  and  antigen was administered simultane- 
ously with the second injection of cells. 
The fraction of donor cells in the intermediate host lymph was determined 
by incubating 5  X  l0  s cells from normal donors with uridine3H in vitro for 45 
min. The cells were subsequently injected into  an intermediate host  and col- 
lected  as  described  above.  Radioautographs  of donor  and  intermediate  host 
lymph obtained in two experiments showed that an average of 84% of cells in 
the donor lymph and 87 % of cells in the host lymph (200 cells counted)  were 
labeled. These results were used to calculate the number of passaged cells trans- 
ferred to recipients challenged with HSF. 
Fig.  5  shows the adoptive primary response to HSF restored by 2,  10,  50, 
and  180  X  106  unpassaged  thoracic  duct  cells  from normal  donors.  The  re- 
sponses restored  by 50  and  180  X  106  cells were  almost identical.  Moderate 
titers were observed at day 12 and a plateau was noted at day 18. A less vigor- 
ous response was restored by 10 X  106 cells,  and that restored by 2 X  106 cells 
was barely detectable by day 20.  Almost all the antibody produced after day 
14 was resistant to 2-ME  (Fig. 5 b). 
The adoptive response produced by 180  X  106 passaged thoracic duct cells 
is also shown in Fig. 5. Although antibody was detectable by day 12, titers did 
not rise thereafter. Titers at days 14,  18, and 20 fell between those restored by 
2 and 10 X  106 unpassaged cells. 
Inability of Thoracic Duct Cells from Thymidine-3H-Treated Donors to Restore 
the  Adoplive  Primary  Antibody  Response  to  HSF.--In  several  experiments, "c 
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thoracic duct cells from unimmunized donors treated with thymidine-3H were 
tested for their ability to restore the adoptive primary response to HSF. Each 
normal  donor  received 24.5  mCi of the radioactive nucleotide for 48 hr before 
cannulation  of  the  thoracic  duct  as  described  previously.  Cells  from treated 
donors were transferred to syngeneic hosts 2 hr after whole body X-irradiation 
and HSF was injected 22 hr later.  Cold thymidine (10  -4 M,  1 ml) was injected 
intraperitoneally  immediately  after  antigenic  challenge  and  thymidine  was 
added to the drinking water (10  -4 M). 
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FIG. 5.  Adoptive antibody response  of rats to a single subcutaneous injection of HSF in 
complete Fieund's adjuvant. Hosts were given an intravenous injection of thoracic duct cells 
from  unimmunized syngeneic  donors  2  hr after 500  R  whole body X-irradiation.  HSF was 
given 22 hr later. (a) Total antibody response.  (b) 2-ME-resistant antibody response.  V--V, 
Mean  response  of rats given 2  X  106 untreated cells;  /k--A,  mean response  of rats given 
10 X  106 untreated cells; O-- ©, mean response of rats given 50 X  106 untreated cells; •--  •, 
mean response  of rats given  180  X  106 untreated cells;  K]--I::], mean response  of rats given 
180  X  106 cells passaged through an irradiated intermediate host. Equal aliquots of cells were 
given 2 and 24 hr after irradiation. B--I,  Mean response of rats given 180  X  106 cells treated 
in vivo with thymidine-3H; A--A,  mean response  of normal  (unimmunized) rats is shown 
for comparison. Brackets show the standard error of the mean. There were five to seven rats 
in each group. 
Fig.  5  shows  the  total  and  2-ME-resistant  antibody  response  restored 
by  180  X  106  thymidine-3H-treated  thoracic  duct  cells.  Antibody  was  not 
detectable  at day  18  and  one out  of five rats  showed  a  small but  detectable 
titer  at day 20.  This response was similar to  that  produced  by 2  X  106  un- 
treated thoracic duct cells (Fig. 5). 
Cooperation between  Thymidine-3H-Treated  or  Passaged  Thoracic  Duct  Cells 860  PHYSIOLOGICAL CHANGES IN  B  LYMPHOCYTES 
from Normal Donors and Spleen Cells  from Xeonatally Thymectomized Donors.- 
Fig.  6  shows  that  the  anti-HSF  response  of neonatally  thymectomized  rats 
at day 12 is similar to that of age controlled normal rats. However, the adop- 
tive response to HSF restored by 50  X  106 thoracic duct or spleen cells from 
neonatally  thymectomized  rats  is  markedly  reduced  as  compared  with  that 
restored by an equal number of cells from normal donors (Fig. 7). 
In  order  to  test  the  hypothesis  that  passaged  or  thymidine3H-tveated 
thoracic  duct  cells  from  normal  donors  lack  B  lymphocytes,  a  combination 
of 50  X  108 spleen cells from thymectomized donors  (a source  of B lympho- 
cytes), and 50 X  106 passaged or thymidine-~H-treated thoracic duct cells from 
normal donors was injected into irradiated hosts.  The reconstituted  rats were 
challenged with HSF as described before.  Fig.  7 shows that none  of the  indi- 
vidual cell inocula restored a detectable anti-HSF response until day 18. How- 
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FIG. 6.  Antibody  response of normal  or neonatally  thymectomized rats  12  days  after  a 
single subcutaneous injection of HSF. Horizontal line represents the mean antibody titer. 
ever, a combination of the spleen cells and passaged thoracic duct cells or spleen 
cells  and  thymidine-3H-treated  thoracic  duct  cells  produced  a  detectable  re- 
sponse by day 14. Thereafter, the response rose rapidly and was similar to that 
restored by 50 X  106 cells from normal donors by day 20 (Fig. 7). In each case, 
the day 20 titer produced by the combination of cells was significantly greater 
(P <0.01)  than the sum of the titers restored by either cell type alone. 
Restoration of the Adoptive Primary Response to HSF with Thoracic Duct Cells 
Incubated In Vitro with Thymidine-3H.--Our  previous studies have shown that 
in vitro incubation of normal thoracic duct cells in tissue culture medium 199 
for  24  hr  markedly  reduces  their  ability  to  restore  the  adoptive  anti-HSF 
response  (10).  However,  in  vitro incubation  of thoracic  duct  cells  in  Ham's 
F12  tissue culture medium with  105;  fetal calf serum for 24 hr  (see Materials SAMUEL STROBER  861 
and Methods for details) does not affect the restorative activity. Fig. 8 shows 
that  1  X  10  s  incubated thoracic  duct  cells produced  an  adoptive  anti-HSF 
response which was almost identical with that produced by 180 X  106 unincu- 
bated cells. The addition of thymidine-3H (specific activity 15 mCi/mmole) at 
a concentration of 10 #Ci/ml to the above culture medium (with cold thymi- 
dine removed) did not alter the restorative action of the incubated cells (Fig. 8). 
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FIG, 7. Adoptive antibody response of rats to a single subcutaneous injection of HSF in 
complete Freund's adjuvant. Hosts were given an intravenous  injection of lymphoid cells 
from unimmunized syngeneic donors 2 hr after 500 R whole body X-irradiation.  HSF was 
given 22 hr later. (a) Total antibody response. (b) 2-ME-resistant antibody response. K]--KI, 
Mean response of rats given 50 X 106 untreated spleen cells from intact donors; O--O, mean 
response of rats given 50 X 106 untreated thoracic duct cells from intact donors; I--I, mean 
response of rats given 50 X  106 untreated spleen cells from thymectomized donors; Q--I, 
mean response of rats given 50 X 106 thoracic duct cells from thymectomized donors; ~---V, 
mean response of rats given 50 X  106 thoracic duct cells treated in vivo with thymidine3H; 
A--A, mean response of rats given 50 X 106 thoracic duct cells passaged through an irradi- 
ated intermediate host; ~,--A, mean response of rats given a combination of 50 X 106 tho- 
racic duct cells treated  in vivo with thymidine3H and 50 X  106 spleen cells from thymec- 
tomized donors; Y--~', mean response of rats  given a combination of 50  X  106 thoracic 
duct cells passaged through an irradiated intermediate host and 50 X 106 spleen cells from a 
thymectomized donor. Brackets  show the  standard  error of the  mean. There  were five to 
seven rats in each group. 
Restoration  of  the  Adoptive  Secondary  Response  to  HSF  with  Passaged  or 
Thymidine-3tt-Treated  Thoracic  Duct  Cells from  Immunized  Donors.--Fig.  9 
shows  the  adoptive anti-HSF response restored  by  2,  10,  20,  and 50  X  106 
thoracic  duct  cells from  donors immunized to  HSF  4-8  wk  before.  The  re- 
sponse restored by 20  and 50  X  106  cells rose  rapidly after  day 8,  but that 
restored  by 2  X  10  6 cells was  not detected until day  14.  Differences in the 862  PHYSIOLOGICAL  CHANGES  IN  B  LYMPHOCYTES 
pre-  and  postboost  titers  of  intact  rats  imnmnized  to  HSF  are  shown  for 
comparison (Fig. 9). 
In  several  experiments  HSF-primed  thoracic  duct  cells  were  passaged 
through  X-irradiated  intermediate  hosts  and  tested  for  their  ability to  re- 
store  the  adoptive  antibody  response  to  HSF.  Fig.  9  shows  that  20  X  106 
passaged  cells produced  a  response  which  was  not  significantly different  in 
time-course and magnitude from that produced by 20 X  106 unpassaged cells. 
Treatment  of HSF-primed donors with  thymidine-3H produced  a  slight re- 
duction in the restorative activity of the primed cells. The  response restored 
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FIo. 8.  Adoptive antibody response of rats to a single subcutaneous  injection of HSF in 
complete Freund's adjuvant. Hosts were given an intravenous injection of thoracic duct cells 
from unimmunized  syngenelc donors  2 hr after 500 R whole body X-irradiation. HSF was 
given 22 hr later. El--r-q, Mean response of 7 rats given 180  X  l0  G  untreated cells;  0--0, 
mean response of 12 rats given 100  X  106 cells incubated in vitro for 24 hr without thymi- 
dine-3H; O--O, mean response of 15 rats given 100 X  106 cells incubated in vitro for 24 hr 
with 10/~Ci/ml  thymidine-~H. Brackets show standard error of the mean. 
by 20  X  106  treated cells was similar to that restored by 10  X  106  untreated 
cells, but  was  considerably greater  than  that  restored by 2  X  106  untreated 
ceils (Fig. 9). 
DISCUSSION 
The  migratory  behavior  and  turnover  rate  of  lymphocytes which  initiate 
the primary and  secondary antibody response of rats to protein antigens was 
investigated. Studies of the primary response of Lewis rats to DT  show  that 
drainage of the thoracic duct of normal rats for 5  days before antigenic chal- 
lenge  does  not  alter  the  magnitude  of  the  anti-DT  response.  Thoracic  duct SAMUEL  STROBER  863 
cells  (1  X  10  °)  from  these  donors do  not restore  the  adoptive  antibody re- 
sponse of sublethal]y irradiated (500 R) hosts. However, spleen cells (1  X  10s)  . 
from normal donors restore a vigorous response. These results indicate that a 
population of  lymphocytes involved in the  primary response to  I)T  do  not 
recirculate from the blood to the lymph, and are, instead, associated with the 
solid lymphoid tissues. 
On the other hand, as few as 1 X  107 thoracic duct cells from rats immunized 
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FIG. 9.  Adoptive antibody response of rats to a single subcutaneous injection of HSF in 
complete Freund's adjuvant. Hosts were given an intravenous injection of thoracic duct cells 
from HSF-primed donors 2 hr after 500 R whole body X-irradiation. HSF was given 22 hr 
later.  O--O, Mean response of rats given 50 X  l0  G  untreated cells; V--V, mean response 
of rats given 20 X 106 untreated cells; O--O, mean response of rats given 10 X 106 untreated 
ceils; &,--A, mean response of rats given 2 X  106 untreated  cells; B-tl, mean response of 
rats given 20  X  106 cells passaged through an irradiated  intermediate host;  []--[3, mean 
response of rats given 20 X 106 cells treated in vivo with thymidine-SH; A--A, mean differ- 
ence in pre- and postboost  titers of intact rats primed to HSF 4--8 wk before is shown for 
comparison. Brackets show the standard  error of the mean. There were five to seven rats in 
each group. 
to DT 4--8 wk earlier restore a vigorous adoptive secondary antibody response. 
It is unlikely that cells from the sublethally irradiated hosts  are involved in 
the response since similar responses are observed in lethally irradiated (1000 R) 
recipients. In addition, Ellis et  al.  (23)  have shown that  thoracic  duct  cells 
from rats primed to tetanus toxoid are the precursors of the antibody-forming 
cells in the adoptive anti-toxoid response of lethally irradiated rats. Antibody- 
forming cells of donor origin were identified by the cytotoxic action of antisera 864  :PHYSIOLOGICAL  CHANGES  IN  B  LYMPHOCYTES 
directed against donor histocompatability antigens on the surface of specifically 
immunofluorescent cells. 
In order to determine whether memory cells are able to recirculate from the 
blood to the lymph, DT-primed thoracic duct cells were injected intravenously 
into normal intermediate hosts and subsequently collected in the thoracic duct 
lymph.  The  passaged  cells  were  compared  with  unpassaged  cells  for  their 
ability to restore the  adoptive secondary response to DT. The yield of DT- 
primed cells in the lymph of the intermediate hosts was determined by labeling 
donor cells with uridine-3H in vitro before cell transfer. The per cent of labeled 
cells in donor and host lymph was used to calculate the number of DT-primed 
cells injected into each irradiated recipient. A comparison of the cell  dose vs. 
antibody response plots of passaged and unpassaged cells shows that passaged 
ceils completely maintain  their restorative activity. 
Although these findings show that memory cells in the thoracic duct lymph 
are able to recirculate from the blood to the lymph the contribution of helper 
cell (T cell) and antibody-forming precursor cell  (B cell) activity was not as- 
sessed.  A decrease in the precursor cell activity of passaged cells could have been 
masked by an increase in helper cell activity. In order to assess both activities, 
a combination of carrier and hapten-primed cells were used to restore the adop- 
tive  antibody  response  to  DNP-DT.  We  have  previously shown  that  both 
cell types cooperate in the initiation of the anti-DNP response to this hapten- 
protein conjugate (20). 
Graded numbers of passaged  or unpassaged DT-primed thoracic duct cells 
with  a  constant  number of DNP-primed  cells were transferred to irradiated 
hosts challenged with DNP-DT. The adoptive anti-DNP  response was taken 
as a measure of helper cell activity and the anti-DT response was taken as a 
measure of precursor cell activity (21, 22). The experimental results show that 
the DT-primed, passaged and unpassaged cells restore quite similar anti-DNP 
and  anti-DT responses. This shows that the majority of both primed, helper 
and precursor cells  are  able to recirculate from the blood to the lymph.  Our 
recent report  that  hapten-primed  thoracic  duct  cells  are  able  to  recirculate 
provides further evidence for this point  (24).  In addition, Howard has shown 
that the majority of uridine-~H-labeled B lymphocytes from the thoracic duct of 
thymectomized, lethally irradiated rats restored with syngeneic bone marrow 
are able to migrate from the blood to the lymph (25). However, the migratory 
pathways of the B lymphocytes differ from those of T  lymphocytes (26). 
A comparison of the studies of the adoptive primary and secondary responses 
to DT suggests that the migratory patterns of unprimed and primed lympho- 
cytes differ. However, one could argue that  active recirculating lymphocytes 
are found both in the thoracic duct lymph and spleens of unimmunized rats. 
The spleen may have an  additional  activity not present in the lymph which 
allows for the full expression of the immunological function of the recirculating 
cells.  In order to show conclusively that the migratory behavior of unprimed SAMUEL  STROBER  865 
and primed lymphocytes differ, we studied the adoptive primary and secondary 
response of rats to another protein, HSF. Both unprimed and primed thoracic 
duct cells are able to restore the antibody response of irradiated hosts to this 
antigen (10). The mechanisms responsible for the differences in the restorative 
action of unprimed thoracic duct cells to HSF and DT have not been elucidated. 
Thoracic  duct  cells  from  unimmunized  donors  were  passaged  through 
irradiated  intermediate  hosts  and  subsequently  tested  for  their  ability  to 
restore the  adoptive response to HSF.  In  vitro labeling  of donor cells with 
uridine-aH showed  that  almost  all  the  cells in  the  intermediate  host  lymph 
are of donor type. The response restored by passaged  cells is reduced 20-  to 
100-fold  as  compared  with  that  produced by  equal  numbers  of unpassaged 
cells.  This indicates that  a  population of thoracic duct cells involved in  the 
adoptive primary response to HSF is unable to recirculate from the blood to 
the  lymph.  In  addition,  the  findings  suggest  that  nonrecirculating  lympho- 
cytes play a  role in the primary response of rats to protein antigens such  as 
DT and HSF whether or not the active cells are found in the thoracic duct 
lymph. 
The turnover rate of thoracic duct cells involved in the  adoptive primary 
response to HSF was  investigated by administering a  large dose (~25  mCi) 
of  thymidine-aH  (specific activity  15  mCi/mmole)  to  unimmunized  donors 
for 48 hr before cannulation of the thoracic duct.  A  24 hr pulse of a  similar 
dose of thymidine-aH in vivo has been reported to reduce the number of colony- 
forming units in mouse bone marrow approximately fivefold (27). The extent 
of "thymidine suicide" depends upon the proliferative rate of the cell popula- 
tion under investigation.  Cells from thymidine-3H-treated donors were trans- 
ferred  to  irradiated  hosts  challenged  with  HSF.  Cold  thymidine  was  ad- 
ministered  to  the  cell  recipients to  minimize  reutilization of the  radioactive 
label. The adoptive primary response restored by the treated cells is approxi- 
mately 100-fold less than that restored by an equal number of untreated cells. 
The  results  show  that  a  population  of  thoracic  duct  cells  involved  in  the 
adoptive response is  newly formed  at  least  every 48  hr.  These findings  are 
consistent with  the  marked reduction in  the  restorative  action of unprimed 
thoracic  duct  cells  after  in  vivo  treatment  with  the  mitotic  inhibitor,  vin- 
blastine  (10).  The newly formed cells are  almost  certainly short lived,  since 
the rate of disappearance of lymphocytes labeled in vivo with thymidine-aH is 
directly related  to  the  rate  of  appearance of the  labeled cells  (28,  29).  The 
short life-span implies either early cell death, or, more probably, continued cell 
division. 
Approximately 5-10% of rat throracic duct cells are large (> 8 ~ diameter) 
lymphocytes which  rapidly incorporate thymidine-aH in vitro  (30).  In  order 
to determine whether these are the short-lived cells involved in the adoptive 
primary response to HSF,  thoracic duct cells from normal donors were incu- 
bated in vitro with  thymidine-aH at  a  concentration of 10 ~,Ci/ml  for 24 hr 866  PHYSIOLOGICAL  CFIANGES  IN  B  LY.~{PHOCYTES 
before cell  transfer.  This concentration  of radioactive thymidine is  100  times 
that which  heavily labels 25-35 ~  of thoracic duct large lymphocytes in vitro 
in  1  hr  (30),  and  abolishes  the  in  vitro  antibody  response  of  mouse 
spleen  cells  to  SRBC  (31).  Our  previous  experiments  showed  that  in  vitro 
incubation of thoracic duct cells in culture medium 199 for 24 hr in the absence 
of radioactive materials markedly reduces their ability to restore the adoptive 
primary response to HSF (10).  However, the tissue culture conditions described 
in  the  present  study  almost completely maintain  the  restorative  action  and 
viability of thoracic duct cells during  the  24 hr period  of incubation without 
radioactive thymidine.  In this way the effects of specific thymidine-~H killing 
of dividing  cells could  be tested.  The  addition  of thymidine-3H to the  tissue 
culture medium did not alter the restorative action of these cells,  and suggests 
that large lymphocytes which divide in the lymph in vitro do not play a  role 
in  the  adoptive primary response.  The experimental results  also suggest  that 
the  active newly  formed  thoracic  duct  cells  enter  the  lymph from a  distant 
generative compartment and do not continue  to divide while they ate in  the 
lymph. 
Experiments with neonatally thymectomized rats suggest that the primary 
antibody response to HSF is independent of T  lymphocytes, since the response 
of intact and thymectomized animals is not significantly different 12 days after 
the  injection  of HSF.  However, thoracic  duct  and  spleen  cells from thymec- 
tomized donors show a marked decrease in their ability to restore the adoptive 
anti-HSF response as compared with equal numbers of cells from intact donors. 
These findings are not surprising in view of the fact that only a small fraction 
of the total number of T  lymphocytes in a normal rodent is required  to com- 
pletely restore the primary response of thymectomized hosts  (16,  32).  A com- 
parison  of the restorative action of limited numbers of cells from normal and 
thymeetomized donors  is,  therefore,  a  more  sensitive  indicator  of T  cell  de- 
pendence than a  comparison of the responses of the donors themselves to the 
same antigen. 
In  several  experiments,  combinations  of passaged or  thymidine-3H-treated 
thoracic  duct cells from normal  donors  and  spleen cells from thymectomized 
donors were tested for their ability to restore the adoptive primary response to 
HSF.  The response restored  by either  combination of cells  was considerably 
greater than the sum of the responses restored by each cell type alone. These 
findings  strongly suggest  that  the population  of nonrecirculating,  short-lived 
(newly formed) cells present in the thoracic duct lymph of unimmunized  rats 
are B lymphocytes, since the restorative activity of passaged or thymidine-3H  - 
treated thoracic duct cells can be reconstituted  with B  cells.  In addition,  the 
results suggest that unprimed T  lymphocytes are recirculating cells which  are 
turning over slowly (long lived).  Definitive evidence for this point is lacking, 
since specific T  or B cell markers are not presently available in the rat. 
Although passaged thoracic duct cells from unimnmnized donors are unable SAMUEL  STROBER  867 
to  restore  the  adoptive  primary  response  to  HSF,  passaged  cells  from  im- 
munized  donors  restore  a  vigorous  secondary  response  which  is  similar  to 
that  produced by an  equal number of unpassaged  cells.  This indicates  that 
there  is  a  fundamental  change  in  the  migratory behavior  of  thoracic  duct 
lymphocytes after exposure to antigen.  Primed  (memory) thoracic duct cells 
are able to recirculate from the blood to the lymph; whereas, unprimed cells 
are not. These results are in agreement with those obtained using DT as anti- 
gen, and serve to explain the differences in the lymphoid tissue distribution of 
unprimed  and  primed  lymphocytes  involved  in  the  adoptive  antibody  re- 
sponse to DT  (9). The altered migratory properties of primed and unprimed 
cells may be related to changes in the cell membrane which occur after prim- 
ing,  since  changes  in  the  homing patterns  of  thoracic  duct  cells have  been 
reported  to  be  related  to  changes  in  the  constituents  of  the  surface  mem- 
brane (33, 34). 
TABLE II 
Thoracic Duct Cells Involved in the Primary and Secondary Antibody Response 
1 ° Antibody  response  2 ~ Antibody  response 
T lymphocytes  T lymphocytes 
Recirculating  Recirculating 
Long lived  Long lived 
B1 lymphocytes  B2 lymphocytes 
Nonrecirculating  Recirculating 
Short lived (newly formed)  Long lived 
Treatment of HSF-primed donors with thymidine-3H for 48 hr before can- 
nulation  of the  thoracic  duct  produced  a  slight  (~2-fold)  reduction in  the 
adoptive secondary response restored by the treated cells.  On the other hand, 
similar treatment of unimmunized donors produced at least a  100-fold reduc- 
tion  in  the  adoptive  primary  response.  These  experimental  results  indicate 
that  the  turnover  rate  of  a  population  of  unprimed  lymphocytes is  much 
greater than that of primed (memory) lymphocytes. The findings are consistent 
with  our previous report of the  markedly increased  sensitivity of unprimed 
thoracic duct  cells  to  the  mitotic  inhibitor,  vindblastine,  as  compared with 
primed  cells  (10).  Experiments  with  DNP-DT  show  that  the  majority  of 
both primed helper (T) and precursor (B) cells are relatively long lived (slowly 
turning over). The slight reduction in the restorative activity of thymidine-3H  - 
treated, primed cells is difficult to interpret, since the reutilization of the radio- 
active label by donor cells was not assessed.  Our previous experiments suggest 
that reutilization could account for the depressed responses, since in vivo treat- 
ment of primed cells with a nonreutilizable mitotic inhibitor, vinblastine, re- 
sulted in augmented adoptive secondary responses to HSF (10). 868  PHYSIOLOGICAL  CHANGES  IN  ]3  LYMPtIOCYTES 
Table  II lists  the  physiological  characteristics  of  primed  and  unprimed  T 
and B lymphocytes suggested by the present study. Both unprimed and primed 
T  cells found in  the thoracic duct lymph are long-lived, recirculating lympho- 
cytes.  On  the  other  hand,  unprimed  B  cells  are  nonrecirculating,  short-lived 
lymphocytes  (B1  cells)  which  undergo  a  fundamental  biological  change  to 
long-lived,  recirculating  lymphocytes  (B._, cells)  found  in  the  thoracic  duct 
lymph after priming.  Changes in the physiological functions of unprimed  and 
primed  B  cells  may parallel  fundamental  changes in  immunological  functions 
recently suggested by several investigators  (4, 5). 
The  rapid  turnover  of  unprimed  B  lymphocytes  may  play  an  important 
role in generating the considerable diversity of antibody combining sites  ("V" 
regions)  of rats  by" means  of continuous  somatic  mutation  or  recombination 
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FIG. 10.  "Clone stabilization."  Two  models are  shown. On the left,  "B"  lymphocytes 
derived from a given stem cell are committed to the expression of a single "V" region. Inter- 
action between antigen and the mature B cell gives rise to a clone of long-lived memory cells 
which also express the identical V region. On the right, somatic mutation  or recombination 
occurs continuously among rapidly dividing B cells or B cell precursors, such that a given B 
cell may express a V region which differs from that of its ancestors. Interaction between anti- 
gen and a transient  mutant or recombinant B cell gives rise to a clone of memory cells which 
express the V region of the unprimed cell during their long life-span. 
(35,  36)  of either  B  cell  precursors or B  cells  themselves.  On the other hand, 
the  long-lived memory B  lymphocytes form more stable  clones of cells which 
may not divide  until  they, are stimulated  by antigen.  Fig.  10 shows  two pos- 
sible  models of  "clone stabilization."  In the  first,  all  B  lymphocytes derived 
ftonl  a  given  stem cell  are  committed  to  the  expression  of a  given  V  region, 
such  that  all  the  progeny,  of  the  rapidly,  dividing  cells  express  the  identical 
antibody combining site.  Interaction between  antigen  and  the  mature  B  cell 
gives rise to a clone of long-lived memory cells which also express the identical 
V  region. 
In the second model, somatic mutation or recombination occurs continuously 
amongst rapidly dividing B  cells or B  cell precursors such that  a  given B  cell 
may express  a V  region which differs from that of its ancestors. The antibody 
combining  site  of  unprhned  B  cells  may change  configurations  as  continued SAMUEL  STROBER  869 
cell  division  proceeds.  Interaction between  antigen  and  a  transient  mutant 
or recombinant B  cell gives rise to a clone of memory cells which continue to 
express the V  region of the unprimed cell during their long life-span. In this 
way, antigen may stabilize the expression of transient mutant or recombinant 
V regions which would otherwise be short lived. 
SUMMARY 
The life-span and migratory characteristics of rat thoracic duct cells which 
initiate the adoptive primary and secondary antibody response to diphtheria 
toxoid  (DT)  and  horse spleen ferritin  (HSF)  were investigated.  The experi- 
mental  results  show  that  thoracic duct lymphocytes from normal  (unimmu- 
nized) donors are able to restore the  adoptive response of irradiated hosts  to 
HSF. Thoracic duct cells passaged through an intermediate host (intravenous 
injection  and  subsequent  collection  in  the  thoracic  duct  lymph)  showed  a 
marked  reduction  in  their  restorative  action  as  compared  with  unpassaged 
cells.  In  addition,  the  restorative  action  of  cells  from  donors  treated  with 
thymidine-3H for 48 hr before cannulation of the thoracic duct was markedly 
decreased.  This  indicates  that  a  population  of lymphocytes involved in  the 
adoptive primary response is unable to recirculate from the blood to the lymph 
and  is  turning  over rapidly  (short  lived).  The  nonrecirculating,  short-lived 
lymphocytes are proably "B"  cells,  since a  combination of spleen cells from 
neonatallv  thymectomized rats  and  passaged  or  thymidine-3H-treated  cells 
restores a vigorous response to HSF. 
On  the  other  hand,  passaged  or  thymidine3H-treated  thoracic  duct  cells 
from donors immunized to DT or HSF are able to restore a vigorous adoptive 
secondary antibody response. Experiments with the hapten-protein conjugate, 
DNP-DT,  show that the majority of both helper  ("T")  and precmsor ("B") 
cells  are  able  to  recirculate  and  are  slowly  turning  over  (long  lived).  The 
findings  suggest  that  T  lymphocytes involved in both  the primary and  sec- 
ondary  antibody  response  are  recirculating,  long-lived  cells.  However,  13 
lymphocytes  involved  in  the  primary  response  are  nonrecirculating,  short- 
lived cells ("BI" cells) which undergo a fundamental physiological change to 
recirculating,  long-lived cells  ("B2" cells)  involved in the secondary antibody 
response. 
I  thank Miss Jeanette Dilley for excellent technical assistance, and Mr. Britton Smith 
(National Cancer Institute) for help with neonatal surgery. I  am indebted to Dr. L. W. La~ 
(National Cancer Institute) for continued interest and aid in this work. 
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